QuickView for Kita-kyushu lung cancer antigen 1 (biogroup)

1. Breast cancer response to doxorubicin and docetaxel
2. Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
3. Xenograft and metastatic tumor gene expression profiles regulated by RAF1
4. Triple-negative breast cancers with residual disease that have recurred after chemotherapy
5. Non-small cell lung cancer clinical stages and outcome

There were no matches for Kita-kyushu lung cancer antigen 1

1. T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1…
2. Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients A…
3. A Phase 1/2 Study of TAK-788 in Japanese Patients
4. Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC…